Lupin Limited announced that its US subsidiary, Lupin Pharmaceuticals Inc (collectively Lupin) has launched the first product from its GAVIS pipeline, Zolpidem Sublingual Tablets, 1.75 mg and 3.5 mg. It received final approval from the United States Food & Drug Administration (FDA) earlier, as well as final clearance from the FTC with 180 days of exclusivity.
Zolpidem Sublingual Tablets, 1.75 mg & 3.5 mg are AB-rated generic equivalent of Purdue Pharma L.P’s Intermezzo Sublingual Tablets, 1.75 mg & 3.5 mg and is indicated for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep.
Intermezzo had US sales of USD$9.46 million, according to IMS MAT December 2015.
Did you know it is normal for humans to wake up during the middle of the nite. The duration of this time can be 15-90 minutes and is normal. It is called first and second sleep. This time is very relaxing and a great time for sex.
I thought Leptin was needed to stop feeling hungry and is something we don’t get enough of if we don’t get enough sleep. Is partially responsible for weight gain.